sherman sorensen md
Program Research | NVI Research
Adult Congenital Heart Disease
Date: 6/9/2005
Procedural and Late Outcomes of Percutaneous Foramen Ovale Closure in 1000 Patients: A Single-Center Experience


Date: 6/9/2005
Use of the Amplatzer® SO Device for Percutaneous Patent Foramen Ovale Closure: Tunnel Reduction Technique and Initial Outcomes


Date: 6/9/2005
Migrane Induction by Brain Micro-Embolization During Contrast Transcranial Doppler Evaluation of Right-to-Left Shunt


Date: 6/9/2005
Late Failure of Percutaneous PFO Closure: Mechanism of Failure and Treatment Options


Date: 5/27/2005
Late Adverse Events After Amplatzer® Closure of Patent Foramen Ovale in 350 Patients With High Risk Stratification for Recurrent Stroke


Date: 5/27/2005
Amplatzer® Patent Foramen Ovale Closure Device Safety and Efficacy: 90-day Event Rates in 490 High Risk Stratified Patients
 
pfo treatment options   amplatzer pfo closure
home  |  patients  |  physicians  |  procedures  |  sherman sorensen  | team  |  facilities  |  faq  |  contact us
creative fire inc web design
© 2011 copyright. all rights reserved. sorensen cardiovascular group
sherman sorensen m.d. - gerald polukoff m.d.
aa  asd  carotid stents  coronary  laoo  migraine  pbv  pfo  tcd